Extending the earlier work on organoid culture establishment, recent efforts used whole-exome sequencing and transcriptome analyses to identify upregulated MYC expression and activating KRAS mutations in patient-derived cervical cancer organoids. The gene discussed is KRAS; the disease is cervical cancer.